Historical record - last NADAC effective date: 4/21/2021
Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by Epic Pharma LLC, priced at $0.0480 per EA under NDC 42806051001. Its NADAC has been published 181 times since Nov 15, 2017.
FDA first approved this application on Mar 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Epic Pharma LLCNDC
42806051001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
4/21/2021
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA207099FDA Approved
3/24/2017
TE Code
AB
On Market Since
3/24/2017
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 181 times since Nov 15, 2017, and over the history we have for it it has risen 18.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0480 per EA |
|---|---|
| All-time high | $0.0601 (Jan 16, 2019) |
| All-time low | $0.0403 (Nov 15, 2017) |
| Median price | $0.0520 |
| Average price | $0.0518 |
| Largest weekly change | -13.8% (Jan 23, 2019) |
| Weeks tracked | 181 |
| Tracking since | Nov 15, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+18.9%
Last surveyed Apr 28, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by Epic Pharma LLC, is $0.0480 per EA (NDC 42806051001), effective Apr 28, 2021.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has risen 18.9%. It has been tracked across 181 weekly CMS publications since Nov 15, 2017.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since Nov 15, 2017, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0403 (Nov 15, 2017) to a high of $0.0601 (Jan 16, 2019), with a median of $0.0520 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 300 MG CAPSULE, is $0.0301 per EA — about 37% below GABAPENTIN 300 MG CAPSULE.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 42806051001) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.